Expert in Technology Commercialisation: Life Sciences; Venture Capital Deal Structuring & Licensing
Expert ID: 729861 Australia
Expert. Expert has hands-on experience in the evaluation of early-stage companies, deal structuring for investment (e.g. venture based placements and convertible debt finance), and licensing agreements focussed on intellectual property rights.
His experience in the assessment of companies makes Expert an ideal consultant to assist with the review and development of business plans and grant applications. His extensive background in deal structuring, valuation and licensing provides a valuable resource to clients seeking advice on negotiating terms (terms sheets) for the access of rights to client intellectual property or raising capital in exchange for equity or other forms of security.
Expert is intermittently employed as a contractor to CIS Consulting in Melbourne. In that capacity Expert provides a number of consulting services including, business plan review, specialty contibutions to grant applications and review, and fundraising advice. Expert is routinely employed by the Victorian Government (i.e. once annually) to provide expert opinion on applications made to the state's Vistech program.
|Year: 1991||Degree: PhD||Subject: Organic Chmistry||Institution: University of Queensalnd, QLD|
|Year: 2001||Degree: Masters Sci Tech Comm||Subject: Science & technology Commercialisation||Institution: Adelaide University, SA|
|Year: 2009||Degree: Exec. Mgmt.||Subject: Private Equity and Venture Capital||Institution: Harvard Business School, Boston, Mass. USA|
|Years: 1994 to 2011||Employer: CSIRO||Title: Executive Manager: Commercial||Department: Intellectual Property & Licensing||Responsibilities: Expert. Expert manages the firm's AU$16M Australian Growth Partnership program and is responsible for the selection of and investment into high potential technology-receptive small to medium sized companies. [www.csiro.au/AGP] Expert. Expert also leads the company's commercialisation and licensing effort for the organisation's RAFT technology.|
|Years: 2002 to 2003||Employer: GBS Venture Partners||Title: Investment Manager||Department:||Responsibilities: As an investment manager in a venture capital firm, Expert was responsible for conducting due diligence on the target investment early-stage opportunity in the life-science space. This requires an understanding of the technology underpinning the company as well as its global competitiveness and therefore return opportunities for the investor. Investment managers must also be familiar with venture deal structuring and IP.|
|Years: 2011 to 2008||Employer: CIS Consulting||Title: Consultant||Department:||Responsibilities: Expert provides ad hoc consultancy services to CIS in order to access his speciality skills and/or to assist when the firm has insufficient capacity to meet client demand.
Expert is particularly helpful in reviewing business plans, or providing advice for clients on deal structuring.
|Years: 1994 to Present||Agency: CSIRO||Role: Executive Manager Commercial||Description: Expert has had a variety of roles. Commencing as a post-Doctoral chemist. Expert was fortunate enough to secure the role of Executive Officer to the Chief Executive for more than 2 years, prior to securing his current position in the organsiation's Intellectual Property & Licensing Group.|
|Years||Country / Region||Summary|
|Years: 1992 to 1994||Country / Region: United States||Summary: Expert became the senior post-doctoral student within a resarch group (of around 40 post-doctoral students) at the University of Florida.
|Associations / Societies|
|Graduate Australian Institute of Company Directors (GAICD)|
|ARKIVOC EDITORIAL BOARD OF REFEREES|
|Publications and Patents Summary|
|Expert has published 15 journal articles in organic chemistry, a list is available on request.|
|Training / Seminars|
|1 day presentation "Commercialsiing Scientific Research" for the Australian Academy of Science, May 2010.
An annual lecture to Monash University Bachelor of Biotechnology:
"Betabiotics - A case study on investing in early stage biotechnology companies."
|Other Relevant Experience|
|He is a non-executive director on two early stage technology based companies.
|French||Expert has completed a graduate French translation course. He would describe his competency levels as: Reading: Good Written: Moderate Spoken: Basic-Moderate|
Fields of Expertise
commercialization, licensable technology, licensing, technology licensing, technology transfer, chemical intellectual property, venture, return on investment, intellectual property management, investment value, private equity fund, international investment, technology acquisition, technology search, proposal writing, technology development, intellectual property, polymer technology, chemical research and development, international technology transfer, fine chemical licensing, chemical manufacturing technology, new technology business value measurement, international licensing, research, pharmaceutical drug, drug, organic compound, polymer